Suter, Thomas

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 | 2006

2016

Schnegg, Bruno; Seiler, Jens; Suter, Thomas; Tanner, Hildegard; Servatius, Helge Simon (2016). Brugada Type 1 ECG Caused by an RVOT Tumor. The Scientific Pages of Heart, 1(1) The Scientific Pages

Zamorano, Jose Luis; Lancellotti, Patrizio; Rodriguez Muñoz, Daniel; Aboyans, Victor; Asteggiano, Riccardo; Galderisi, Maurizio; Habib, Gilbert; Lenihan, Daniel J; Lip, Gregory Y H; Lyon, Alexander R; Lopez Fernandez, Teresa; Mohty, Dania; Piepoli, Massimo F; Tamargo, Juan; Torbicki, Adam; Suter, Thomas; Zamorano, Jose Luis; Aboyans, Victor; Achenbach, Stephan; Agewall, Stefan; ... (2016). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). European journal of heart failure, 19(1), pp. 9-42. Wiley 10.1002/ejhf.654

2015

Beauchamp, Philippe; Ullrich, Nina; Jens, Kelm; Moritz, Wolfgang; Agarkova, Irina; Anson, Blake; Suter, Thomas; Zuppinger, Christian (2015). Development and characterization of a scaffold-free 3D spheroid model of iPSC-derived human cardiomyocytes. Tissue Engineering Part C: Methods, 21(8), pp. 852-861. Mary Ann Liebert 10.1089/ten.tec.2014.0376

Rutz, E; Suter, Thomas; Slongo, Theddy; Brunner, Roland (2015). Osteotomy of the distal femur. Surgical technique using the LCP Pediatric Condylar Plate 90°. Operative Orthopädie und Traumatologie, 27(3), pp. 221-236. Springer 10.1007/s00064-015-0401-0

2014

Raschle, Joëlle; Banz Wälti, Yara; Suter, Thomas; Pabst, Thomas (2014). A single-centre cohort of patients with systemic light chain AL-amyloidosis treated with conventional chemotherapy or with high-dose chemotherapy and autologous stem cell transplantation. Swiss medical weekly, 144, w13922. EMH Schweizerischer Ärzteverlag 10.4414/smw.2014.13922

2013

Goldhirsch, Aron; Gelber, Richard D.; Piccart-Gebhart, Martine J.; de Azambuja, Evandro; Procter, Marion; Suter, Thomas; Jackisch, Christian; Cameron, David; Weber, Harald A.; Heinzmann, Dominik; Dal Lago, Lissandra; McFadden, Eleanor; Dowsett, Mitch; Untch, Michael; Gianni, Luca; Bell, Richard; Köhne, Claus-Henning; Vindevoghel, Anita; Andersson, Michael; Brunt, A Murray; ... (2013). 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial. Lancet, 382(9897), pp. 1021-1028. Elsevier 10.1016/S0140-6736(13)61094-6

Cameron, David; Brown, Julia; Dent, Rebecca; Jackisch, Christian; Mackey, John; Pivot, Xavier; Steger, Guenther G.; Suter, Thomas M.; Toi, Masakazu; Parmar, Mahesh; Laeufle, Rita; Im, Young-Hyuck; Romieu, Gilles; Harvey, Vernon; Lipatov, Oleg; Pienkowski, Tadeusz; Cottu, Paul; Chan, Arlene; Im, Seock-Ah; Hall, Peter S.; ... (2013). Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial. The lancet oncology, 14(10), pp. 933-942. Elsevier 10.1016/S1470-2045(13)70335-8

Suter, Thomas; Ewer, Michael S. (2013). Cancer drugs and the heart: importance and management. European Heart Journal, 34(15), pp. 1102-1111. Oxford University Press 10.1093/eurheartj/ehs181

2012

Chiusa, Manuel; Hool, Sara-Lynn; Truetsch, Petra; Djafarzadeh, Siamak; Jakob, Stephan M; Seifriz, Franziska; Scherer, Stefan J; Suter, Thomas M; Zuppinger, Christian; Zbinden, Stephan (2012). Cancer therapy modulates VEGF signaling and viability in adult rat cardiac microvascular endothelial cells and cardiomyocytes. Journal of molecular and cellular cardiology, 52(5), pp. 1164-75. Oxford: Elsevier 10.1016/j.yjmcc.2012.01.022

Dimitrakis, Polychronis; Romay-Ogando, Maria-Iris; Timolati, Francesco; Suter, Thomas M; Zuppinger, Christian (2012). Effects of doxorubicin cancer therapy on autophagy and the ubiquitin-proteasome system in long-term cultured adult rat cardiomyocytes. Cell and tissue research, 350(2), pp. 361-72. Heidelberg: Springer 10.1007/s00441-012-1475-8

Chiusa, M; Timolati, F; Perriard, J C; Suter, T M; Zuppinger, C (2012). Sodium nitroprusside induces cell death and cytoskeleton degradation in adult rat cardiomyocytes in vitro: implications for anthracycline-induced cardiotoxicity. European journal of histochemistry, 56(2), e15. Pavia: Luigi Ponzio 10.4081/ejh.2012.e15

2011

Rochlitz, C; Ruhstaller, T; Lerch, S; Spirig, C; Huober, J; Suter, T; Bühlmann, M; Fehr, M; Schönenberger, A; von Moos, R; Winterhalder, R; Rauch, D; Müller, A; Mannhart-Harms, M; Herrmann, R; Cliffe, B; Mayer, M; Zaman, K; Swiss Group for Clinical Cancer Research (SAKK), (2011). Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06). Annals of oncology, 22(1), pp. 80-5. Oxford: Oxford University Press 10.1093/annonc/mdq319

2010

Harbeck, N; Ewer, M S; De Laurentiis, M; Suter, T M; Ewer, S M (2010). Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy. Annals of oncology, 22(6), pp. 1250-1258. Oxford: Oxford University Press 10.1093/annonc/mdq543

Stortecky, Stefan; Suter, Thomas M (2010). Insights into cardiovascular side-effects of modern anticancer therapeutics. Current opinion in oncology, 22(4), pp. 312-7. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/CCO.0b013e32833ab6f1

Zuppinger, Christian; Suter, Thomas M (2010). Cancer therapy-associated cardiotoxicity and signaling in the myocardium. Journal of cardiovascular pharmacology, 56(2), pp. 141-6. Hagerstown, Md.: Wolters Kluwer Lippincott Williams & Wilkins 10.1097/FJC.0b013e3181e0f89a

Procter, Marion; Suter, Thomas M; de Azambuja, Evandro; Dafni, Urania; van Dooren, Veerle; Muehlbauer, Susanne; Climent, Miguel Angel; Rechberger, Ernst; Liu, Walter Tsang-Wu; Toi, Mazakasu; Coombes, R Charles; Dodwell, David; Pagani, Olivia; Madrid, Jorge; Hall, Marcia; Chen, Shin-Cheh; Focan, Christian; Muschol, Michael; van Veldhuisen, Dirk J and Piccart-Gebhart, Martine J (2010). Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial. Journal of clinical oncology, 28(21), pp. 3422-8. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2009.26.0463

2009

Timolati, Francesco; Anliker, Tobias; Groppalli, Vittoria; Perriard, Jean-Claude; Eppenberger, Hans M; Suter, Thomas M; Zuppinger, Christian (2009). The role of cell death and myofibrillar damage in contractile dysfunction of long-term cultured adult cardiomyocytes exposed to doxorubicin. Cytotechnology, 61(1-2), pp. 25-36. Dordrecht: Springer 10.1007/s10616-009-9238-4

Pentassuglia, Laura; Graf, Michael; Lane, Heidi; Kuramochi, Yukio; Cote, Gregory; Timolati, Francesco; Sawyer, Douglas B; Zuppinger, Christian; Suter, Thomas M (2009). Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes. Experimental cell research, 315(7), pp. 1302-12. San Diego, Calif.: Elsevier 10.1016/j.yexcr.2009.02.001

Noti, F; Zimmerli, S; Goerre, S; Carrel, T; Suter, T (2009). [Does yoghurt gnaw at cardiac valves?]. Praxis - schweizerische Rundschau für Medizin, 98(10), pp. 547-50. Bern: Huber

de Azambuja, Evandro; Bedard, Philippe L; Suter, Thomas; Piccart-Gebhart, Martine (2009). Cardiac toxicity with anti-HER-2 therapies: what have we learned so far? Targeted oncology, 4(2), pp. 77-88. Paris: Springer 10.1007/s11523-009-0112-2

Pfisterer, Matthias; Buser, Peter; Rickli, Hans; Gutmann, Marc; Erne, Paul; Rickenbacher, Peter; Vuillomenet, André; Jeker, Urs; Dubach, Paul; Beer, Hansjürg; Yoon, Se-Il; Suter, Thomas; Osterhues, Hans H; Schieber, Michael M; Hilti, Patrick; Schindler, Ruth; Brunner-La Rocca, Hans-Peter (2009). BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA - the journal of the American Medical Association, 301(4), pp. 383-92. Chicago, Ill.: American Medical Association 10.1001/jama.2009.2

2007

Pentassuglia, Laura; Timolati, Francesco; Seifriz, Franziska; Abudukadier, Kaisaier; Suter, Thomas M; Zuppinger, Christian (2007). Inhibition of ErbB2/neuregulin signaling augments paclitaxel-induced cardiotoxicity in adult ventricular myocytes. Experimental cell research, 313(8), pp. 1588-601. San Diego, Calif.: Elsevier 10.1016/j.yexcr.2007.02.007

Zuppinger, Christian; Timolati, Francesco; Suter, Thomas M (2007). Pathophysiology and diagnosis of cancer drug induced cardiomyopathy. Cardiovascular toxicology, 7(2), pp. 61-6. New York, N.Y.: Springer 10.1007/s12012-007-0016-2

Suter, Thomas M; Procter, Marion; van Veldhuisen, Dirk J; Muscholl, Michael; Bergh, Jonas; Carlomagno, Chiara; Perren, Timothy; Passalacqua, Rodolfo; Bighin, Claudia; Klijn, Jan G M; Ageev, Fail T; Hitre, Erika; Groetz, Juergen; Iwata, Hiroji; Knap, Malgorzata; Gnant, Michael; Muehlbauer, Susanne; Spence, Alison; Gelber, Richard D and Piccart-Gebhart, Martine J (2007). Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. Journal of clinical oncology, 25(25), pp. 3859-65. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2006.09.1611

2006

Timolati, Francesco; Ott, Daniel; Pentassuglia, Laura; Giraud, Marie-Noëlle; Perriard, Jean-Claude; Suter, Thomas M; Zuppinger, Christian (2006). Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes. Journal of molecular and cellular cardiology, 41(5), pp. 845-54. Oxford: Elsevier 10.1016/j.yjmcc.2006.08.002

Provide Feedback